Savvas Damdoumis

Savvas Damdoumis

Auto-generated profile, based on publicly available information

Savvas Damdoumis

Aristotle University of Thessaloniki, Faculty of Sciences, School of Biology, Department of Genetics, Development and Molecular Biology, Thessaloniki, Greece

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in Heart, Lung and Circulation
Verified
Journal Article
Open access
Stefanos T. PapageorgiouStefanos T. Papageorgiou
Stefanos T. Papageorgiou
SDSavvas Damdoumis
Savvas Damdoumis
Dimitrios G. GoulisDimitrios G. Goulis
Dimitrios G. Goulis
STStergios Tzikas
Stergios Tzikas
George GiannakoulasGeorge Giannakoulas
George Giannakoulas
Severe COVID-19 can cause acute respiratory distress syndrome, hypoxia, systemic complications, and increased mortality. Pulmonary hypertension (PH) is a major global health issue associated with worsening symptoms and increased mortality. This systematic review aimed to assess the influence of PH onset among COVID-19 patients on all-cause mortality and intensive care unit (ICU) admission. An unrestricted search of five databases up to June 2022 was undertaken. Pulmonary hypertension was assessed using transthoracic echocardiogram, computed tomography, or right heart catheterisation. After duplicate screening, data extraction, and risk of bias assessment, random effects meta-analyses of odds ratios (OR) and their 95% confidence intervals (CI) were performed for all-cause mortality and ICU admission. From the 26 studies that were included (3,373 patients, 76% males, median age 62.6 years), PH in COVID-19 patients was significantly associated with higher odds for all-cause mortality (26 studies; OR 3.89; 95% CI 2.85-5.31; p<0.001) and higher odds for ICU admission (six studies; OR 2.50; 95% CI 1.69-3.70; p<0.001). Meta-regression/subgroup analyses by patient demographics, comorbidities, or therapeutic regimens, and sensitivity analyses did not find any differences. Evidence from observational studies indicates that PH in COVID-19 patients is associated with increased odds of mortality and ICU admission.